🛡️ Public data only — no PHI permitted on this instance.

HOSP

ASPIRUS RIVERVIEW HOSPITAL & CLINICS

CCN 520033|LOC WISCONSIN RAPIDS, WI|BEDS 44|NPR $161.3M|MARGIN 13.1%

C-

SeekingChartis Score

INVESTMENT THESIS

Buy: ASPIRUS RIVERVIEW HOSPITAL & CLINIC

/ 100 (B)

+$11.9M

EBITDA Uplift

+736bps

Margin Δ

0.0%

Op Margin

$161.3M

Revenue

—

Realization

—

Peer Rank

SIGNAL STRENGTH

Margin

0.0%

Safety

62%

CATALYSTS

▲RCM uplift of $11.9M (+736bps)

RISKS

▼Small facility — limited scale economies

Buy — solid fundamentals with identifiable value creation levers. Proceed to detailed diligence.

Peer Analysis EBITDA Bridge Data Room IC Memo ML Detail

$161.3M

Net Patient Revenue

13.1%

Operating Margin

$21.1M

Net Income

Licensed Beds

$3,665K

Revenue per Bed

$140.2M

Operating Expenses

Payer Mix

PYR

■ MEDICARE · 25%■ MEDICAID · 5%■ COMMERCIAL · 70%

Score Breakdown

SCComposite · 51/100

Component	Score	Max	%
Market Position	12	35	35%
Financial Health	23	25	91%
Operational Quality	0	20	0%
Competitive Moat	6	20	29%

Comparable Hospitals

CMP

CCN	Hospital	Beds	NPR
520002	ASPIRUS STEVENS POINT HOSPITAL	82	$0M
520004	MCHS FRANCISCAN HEALTHCARE INC	103	$0M
520008	WAUKESHA MEMORIAL HOSPITAL	270	$0M
520009	ASCENSION NE WISCONSIN-ST. ELIZABETH	287	$0M
520011	LAKEVIEW MEDICAL CENTER OF RICE LAKE	40	$0M

Team Notes

NOTE0 entries

Actions

ACT

WFDiligence Workflow

Competitive Intel EBITDA Bridge Data Room IC Memo Scenarios

AIDeep Analysis

ML Analysis Demand 3-Year History Stats Bayesian

FINFinancial Models

DCF LBO 3-Statement Returns Market Denial

MORE IN WIStart Diligence · creates a deal from HCRIS